The Latest Technology News in Clinical Research

Technology Solutions

1 2 3 4 5 6 7 8 9 10 Next 10

Smith & Nephew and Essex Woodlands share resources to create Bioventus

Friday, January 6, 2012 09:44 AM

Smith & Nephew, a U.K.-based global media technology business, established a joint biologics venture with Essex Woodlands (U.S.), a special healthcare growth equity and venture capital firm headquartered in Durham, N.C. The move will bolster Essex Woodland’s pre-existing biologics and clinical therapies division in Durham, while Smith & Nephew will receive approximately $98 million cash and a $160 million five-year note from the new entity, Bioventus.

More... »

Quintiles forms Digital Patient Unit

Tuesday, January 3, 2012 01:14 PM

Quintiles has formed a Digital Patient unit which brings together the company’s online communities and digital expertise to directly engage patients.

More... »

Ambry Genetics launches Illumina MiSeq Next-Gen sequencing services

Wednesday, December 28, 2011 01:22 PM

Ambry Genetics has launched Illumina MiSeq Next-Gen sequencing services. Ambry Genetics has been an early adapter of Illumina sequencing systems since 2007 and has experience as a Certified Service Provider processing thousands of samples.

More... »

Marken launches SOLO to manage clinical trials distribution

Wednesday, December 7, 2011 12:53 PM

Marken has launched Solo, their proprietary web based system used to manage the regulatory, inventory and operational supply chain complexities of clinical trials. The system, which has been developed exclusively for Marken, is designed to manage all aspects of Marken’s global depot network including: receipt of clinical supplies and kits, dispatches, returns, warehouse movements and QA releases. Solo is a secure, validated, web-based system which is fully accessible to Marken’s clients on a 24/7 basis from any location in the world. Marken has designed Solo to integrate with multiple client-directed IXR (Interactive Reporting) systems.

More... »

HighQ partners with SAFE-BioPharma

Wednesday, December 7, 2011 12:23 PM

London-based HighQ has formed a vendor partnership with the SAFE-BioPharma Association. Companies within the global pharmaceutical and biotechnology industry use the SAFE-BioPharma standard in FDA Title 21 CFR part 11 compliant processes for signing SOPs, quality and compliance documentation, research and development documentation, corporate compliance documents and more.

More... »

Almac launches COMPASS platform to improve clinical trial management

Wednesday, December 7, 2011 10:21 AM

Almac has launched of its new forecasting platform, COMPASS, which has been designed to improve the accuracy and efficiency of the supply inventory process during clinical studies. COMPASS provides benefits to clients by allowing the Supply Chain Manager to proactively direct the entire clinical supply chain, ultimately saving money that is often lost through inaccurate forecasting or overproduction of supplies.

More... »

DATATRAK named CDISC Registered Solutions Provider

Tuesday, December 6, 2011 01:28 PM

DATATRAK International has been recognized as a CDISC Registered Solutions Provider. DATATRAK has been registered as a CDISC consultant, system integrator and subject matter expert in the following CDISC standards: Clinical Data Acquisition Standards Harmonization (CDASH); Laboratory Data Model (LAB); Operational Data Model (ODM); Study Data Tabulation Model (SDTM).

More... »

Healthcare Team Training, IDEAS launch StoryCare

Friday, December 2, 2011 11:55 AM

Atlanta, GA-based Healthcare Team Training and IDEAS based in Orlando, FL, have partnered to launch StoryCare, the first enterprise-wide, staff-deployed teamwork simulation program using the power of story to measurably improve
patient safety and satisfaction.

More... »

Onconova extends agreement with BioClinica

Wednesday, November 30, 2011 02:54 PM

BioClinica has reported that Onconova Therapeutics has extended agreements using BioClinica Express electronic data capture (EDC) and data management services to support their clinical trials world-wide. Onconova has a number of clinical-stage products and a growing number of pre-clinical candidates. These development stage compounds are novel small molecules for the treatment of a broad range of hematologic malignancies and solid tumors.

More... »